Qube Research & Technologies LTD Aurinia Pharmaceuticals Inc. Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$4.93 - $9.31 $848,714 - $1.6 Million	172,153 New	172,153 $862,000
Q3 2023 Nov 13, 2023	BUY	$7.77 - $12.27 $554,607 - $875,808	71,378 New	71,378 $554,000
Q4 2022 Feb 14, 2023	BUY	$4.11 - $8.14 $72,109 - $142,816	17,545 New	17,545 $75,000
Q2 2022 Aug 15, 2022	SELL	$8.95 - $12.8 $1 Million - $1.43 Million	-111,809 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$10.05 - $22.48 $1.12 Million - $2.51 Million	111,809 New	111,809 $1.38 Million

191

56.2M

499K

637K

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.03B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.